Incyte exec exercises options, sells 2,207 shares

INCYTE CORP EVP & Chief Scientific Officer Patrick A. Mayes exercised employee stock options covering 2,207 shares at $106.47 on August 5, 2026, then sold 2,207 common shares at $123.99 per share under a Rule 10b5-1 trading plan.

Rhea-AI Filing Summary

INCYTE CORP EVP & Chief Scientific Officer Patrick A. Mayes exercised employee stock options covering 2,207 shares at $106.47 on August 5, 2026, then sold 2,207 common shares at $123.99 per share under a Rule 10b5-1 trading plan.

Footnotes state the option award was fully vested and exercisable as of that date and note 59,537 shares of common stock issuable from previously reported restricted stock units that have not vested.

Insider Trade Summary 10b5-1

Exercise and Sale: 2,207 shares ($39K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Mayes Patrick A

Role EVP & Chief Scientific Officer

Sold 2,207 shs ($274K)

Approx. gross sale proceeds $274K

Approx. exercise cost $235K

Approx. pre-tax spread $39K

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (right to buy) F2	2,207	$0.00	$0.00
Exercise	Common Stock	2,207	$106.47	$235K
Sale	Common Stock F1	2,207	$123.99	$274K

Holdings After Transaction: Employee Stock Option (right to buy) — 0 contracts (Direct); Common Stock — 61,441 shares (Direct)

Footnotes (2)

1. F1. This includes an aggregate of 59,537 shares of common stock issuable pursuant to previously reported restricted stock units have not vested.
2. F2. As of August 5th, 2026, the award is fully vested and exercisable

Key Figures

Options exercised: 2,207 shares Option exercise price: $106.47 per share Shares sold: 2,207 shares +3 more

6 metrics

Options exercised 2,207 shares Employee stock options converted into common stock on 2026-08-05

Option exercise price $106.47 per share Exercise price for the employee stock option covering 2,207 shares

Shares sold 2,207 shares Common stock sold on 2026-08-05 following the option exercise

Sale price $123.99 per share Per-share price for the sale of 2,207 Incyte common shares

Unvested RSUs 59,537 shares Shares of common stock issuable from previously reported restricted stock units that have not vested

Option expiration date 2030-07-01 Expiration date of the employee stock option prior to its exercise

Key Terms

Employee Stock Option (right to buy), restricted stock units, fully vested and exercisable, Rule 10b5-1

4 terms

Employee Stock Option (right to buy) financial

"Security title reported as Employee Stock Option (right to buy) for 2,207 shares"

restricted stock units financial

"Footnote notes 59,537 shares of common stock issuable pursuant to previously reported restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

fully vested and exercisable financial

"Footnote states that as of August 5th, 2026, the award is fully vested and exercisable"

Rule 10b5-1 financial

"Transactions are indicated as effected pursuant to a Rule 10b5-1 trading plan"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Incyte (INCY) report for Patrick A. Mayes on August 5, 2026?

Incyte reported that EVP Patrick A. Mayes exercised employee stock options for 2,207 shares at $106.47 and sold 2,207 common shares at $123.99 on August 5, 2026, with the trades executed under a Rule 10b5-1 trading plan.

At what prices did Incyte (INCY) executive Patrick A. Mayes exercise and sell his shares?

Patrick A. Mayes exercised options to acquire 2,207 Incyte shares at an exercise price of $106.47 per share and sold 2,207 common shares at a sale price of $123.99 per share on the same date.

Were Patrick A. Mayes’s Incyte (INCY) trades made under a Rule 10b5-1 plan?

Yes. The filing indicates the Rule 10b5-1 checkbox is marked, meaning the reported transactions were effected under a Rule 10b5-1 pre-arranged trading plan, which is designed to allow executives to sell shares according to preset instructions.

What unvested equity awards does Patrick A. Mayes still have at Incyte (INCY)?

A footnote states that his holdings include 59,537 shares of common stock issuable pursuant to previously reported restricted stock units that have not yet vested, indicating a substantial remaining equity-based compensation position separate from the shares involved in this transaction.

What type of security did Patrick A. Mayes exercise in this Incyte (INCY) Form 4 filing?

He exercised an Employee Stock Option (right to buy) for 2,207 shares of common stock at an exercise price of $106.47, with the option reported as fully vested and exercisable as of August 5, 2026, and expiring on 2030-07-01.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/07/2026 - 04:02 PM Accepted by SEC EDGAR 08/07/2026 - 04:01 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mayes Patrick A

(Last) (First) (Middle)

1801 AUGUSTINE CUT-OFF

(Street)

WILMINGTON DELAWARE 19803

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
INCYTE CORP [ INCY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Scientific Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/05/2026		M		2,207	A	$106.47	63,648	D
Common Stock	08/05/2026		S		2,207	D	$123.99	61,441(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$106.47	08/05/2026		M			2,207	(2)	07/01/2030	Common Stock	2,207	$0	0	D

Explanation of Responses:

1. This includes an aggregate of 59,537 shares of common stock issuable pursuant to previously reported restricted stock units have not vested.

2. As of August 5th, 2026, the award is fully vested and exercisable

Remarks:

	/s/ Elizabeth Feeney, Attorney-In-Fact	08/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)